Neostigmine Methylsulfate — Class II drug recall D-0129-2018
Terminated recall by Premier Pharmacy Labs Inc, reported 2017-12-27, distributed in FL, MD, MI, MN, NC, OH. Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stabil
| Recall number | D-0129-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Premier Pharmacy Labs Inc, Weeki Wachee, FL, United States |
| Recall initiated | 2017-08-10 |
| Classified | 2017-12-21 |
| Reported by FDA | 2017-12-27 |
| Terminated | 2018-03-29 |
| Distributed | FL, MD, MI, MN, NC, OH |
| Quantity | 1,610 syringes |
| Reason classes | labeling, specification failure |
| NDC | 69623-0234-15 |
| Lot numbers | NEO071317MMDSA, NEO071317MMDSC, NEO071317MMDSF |
| Expiration dates | 2018-01-19 |
Product
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
Reason for recall
Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0129-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.